Neeraj Saini1,2, Sattva S Neelapu3. 1. Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 2. Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 3. Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sneelapu@mdanderson.org.
Authors: Nicholas J Haradhvala; Mark B Leick; Katie Maurer; Satyen H Gohil; Rebecca C Larson; Ning Yao; Kathleen M E Gallagher; Katelin Katsis; Matthew J Frigault; Jackson Southard; Shuqiang Li; Michael C Kann; Harrison Silva; Max Jan; Kahn Rhrissorrakrai; Filippo Utro; Chaya Levovitz; Raquel A Jacobs; Kara Slowik; Brian P Danysh; Kenneth J Livak; Laxmi Parida; Judith Ferry; Caron Jacobson; Catherine J Wu; Gad Getz; Marcela V Maus Journal: Nat Med Date: 2022-09-12 Impact factor: 87.241
Authors: Samantha L Bucktrout; Nicholas E Banovich; Lisa H Butterfield; Cansu Cimen-Bozkus; Josephine R Giles; Zinaida Good; Daniel Goodman; Vanessa D Jonsson; Caleb Lareau; Alexander Marson; Denna M Maurer; Paul V Munson; Mike Stubbington; Sarah Taylor; Abbey Cutchin Journal: Nat Med Date: 2022-09 Impact factor: 87.241
Authors: Nathalie Scholler; Regis Perbost; Frederick L Locke; Michael D Jain; Sarah Turcan; Corinne Danan; Edmund C Chang; Sattva S Neelapu; David B Miklos; Caron A Jacobson; Lazaros J Lekakis; Yi Lin; Armin Ghobadi; Jenny J Kim; Justin Chou; Vicki Plaks; Zixing Wang; Allen Xue; Mike Mattie; John M Rossi; Adrian Bot; Jérôme Galon Journal: Nat Med Date: 2022-08-29 Impact factor: 87.241